Criteria:
|
Description:
|
|
Company Stage
|
Start-up to intermediary stage, occasionally seed Disruptive global technology, products or service Patents in some industries Barrier to entry through technology or first-mover advantage
|
|
Market
|
Substantial if successful
|
|
Management
|
Exceptional key persons, not necessarily complete team
|
|
Teknoinvest's Role
|
Clear value adding opportunities
|
|
Industry Areas
|
Life Sciences Clean Tech Nanotech
|
|
Geography
|
Primarily EU, US and Russian origin or association
|
Criterion:
|
Description:
|
|
Investment Vehicle
|
Mainly equity Equity-derivatives Convertible debt Bridge loans as part of equity deal
|
|
Investment Size
|
Normally 1-10 million incl. follow-up investments No single investment >20% of active fund
|
|
Investor Role
|
Minority position No other external controlling party Lead investor, or Together with reputable, trustworthy lead investor Availability of exit through listing, trade sale or merger
|